Blood Immune Markers to Detect Cervical Changes in HPV-Positive Women
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses a special blood test to identify immune markers that may help detect early cervical changes caused by HPV16 or HPV18. If successful, this could offer a simpler way to find cervical problems earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have tested positive for HPV16 or HPV18
- You have a recent cervical cytology (Pap smear) result available
- You are willing to have a colposcopy (close examination of the cervix) and possibly a cervical biopsy (small tissue sample)
- You are not pregnant or breastfeeding
- You have no active infection or serious immune system disease
- You can attend follow-up visits and comply with study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This trial collects blood samples from women with HPV-related cervical cancer to see if a test can detect tiny bits of cancer DNA (molecular residual disease) and predict if the cancer might come back. Finding this DNA early could help guide future treatment decisions.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
This trial tests a personalized blood test that looks for tumor DNA to monitor cervical cancer and help guide treatment decisions. It is for people with advanced or returning cervical cancer who haven't started treatment yet.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
Hear when a new CIN 2/3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.